TRLS-01. FDA ANALYSIS OF EXPANDED ACCESS USE IN PEDIATRIC PATIENTS WITH CNS TUMORS FROM 2015 TO 2020

Few therapies are approved for children with central nervous system (CNS) tumors, and their prognosis is often poor. Expanded Access (EA) is a regulatory mechanism enabling patients with life-threatening or serious diseases to receive treatment with investigational drugs outside of clinical trials w...

Descripción completa

Detalles Bibliográficos
Autores principales: Duke, Elizabeth, Kormanik, Natasha, Barone, Amy, Chan, Mitchell, Antony, Ramya, Drezner, Nicole, Kluetz, Paul, Kim, Tamy, Singh, Harpreet, Pazdur, Richard, Donoghue, Martha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Translational Therapeutics/Clinical Trials - TRLS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260034/
http://dx.doi.org/10.1093/neuonc/noad073.304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260034/
http://dx.doi.org/10.1093/neuonc/noad073.304

Ejemplares similares